New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study-Reference-Cited by-同舟云学术

New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study

Published:2020-11-18 Issue: Volume: Page:
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Yajima Satoshi,Suzuki Takashi,Oshima Yoko,Shiratori Fumiaki,Funahashi Kimihiko,Kawai Shinichi,Nanki Toshihiro,Muraoka Sei,Urita Yoshihisa,Saida Yoshihisa,Okazumi Shinichi,Kitagawa Yuko,Hirata Yuki,Hasegawa Hirotoshi,Okabayashi Koji,Murakami Masahiko,Yamashita Takeshi,Kato Rei,Matsubara Hisahiro,Murakami Kentaro,Nakajima Yasuaki,Sugita Hironobu,Klammer Martin,Shimada Hideaki^ORCID

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-020-09342-4.pdf

Reference23 articles.

1. Soussi T. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 2000;60(7):1777–88.

2. Suppiah A, Greenman J. Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer. World J Gastroenterol. 2013;19(29):4651–70.

3. Shimada H. p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. Ann Gastroenterol Surg. 2018;2(4):266–73.

4. Kunizaki M, Hamasaki K, Wakata K, et al. Clinical value of serum p53 antibody in the diagnosis and prognosis of esophageal squamous cell carcinoma. Anticancer Res. 2018;38(3):1807–13.

5. Tokunaga R, Sakamoto Y, Nakagawa S, Yoshida N, Baba H. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment. Surg Today. 2017;47(5):636–42.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and application of multiple particle binding-liposomes for electrochemiluminescent signal amplification in bioassays;Analytical and Bioanalytical Chemistry;2024-09-14

2. Salivary metabolomic biomarkers for esophageal and gastric cancers by liquid chromatography–mass spectrometry;Cancer Science;2024-07-14

3. HDS screening with patient-derived primary cells guided individualized therapy for esophageal squamous cell carcinoma–in vivo and vitro;Frontiers in Medicine;2023-08-02

4. Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis;Biosensors;2023-06-27

5. Effect of neoadjuvant therapy on serum transforming growth factor-β, squamous cell carcinoma associated antigen, and prognosis in patients with locally advanced esophageal cancer;Cellular and Molecular Biology;2023-05-31